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Insulin receptors were solubilized from rat liver microsomes by the nonionic detergent Triton X-100. After 
gel filtration of the extract on Sepharose CL-6B, two insulin-binding species (peak I and peak li) were obtained. 
The structure and binding properties of both peaks were characterized. Gel filtration yielded Stokes radii of 
9.2 nm (peak I) and 8.0 nm (peak Il). Both peaks were glycoproteins. At 4°C peak 1 showed optimal insulin 
binding at pH 8.0 and high ionic strength. In contrast, peak li bad its binding optimum at pH 7.0 and low ionic 
strength, where peak I bindingwas minimal. For peak I the change in insulin binding under different conditions 
of pH and ionic strength was due to a change in receptor affinity only. For peak 11 an additional change in 
receptor number was found. Both peaks yielded non-linear Scatchard plots under most of the buffer conditions 
examined. At their binding optima at 4 oc the high affinity dissociation constants were 0.50 nM (peak I) and 
0.55 nM (peak II). 
Sodium dodecyl sulfatejpolyacrylamide gel electrophoresis of peak I revealed five receptor bands with Mr 
400000, 365000, 320000, 290000, and 245000 under non-reducing conditions. For peak li two major receptor 
bands with Mr 210000 and 115000 were found. The peak II receptor bands were also obtained aftermild reduction 
of peak I. After complete reduction both peaks showed one major receptor band with Mr 130000. The reductive 
generation of the peak II receptor together with molecular mass estimations suggest that the peak I receptor is 
the disulfide-linked dimer of the peak II receptor. Thus, Triton extracts from rat liver microsomes contain two 
receptor species, which are related, but differ considerably in their size and insulin-binding properties. 
Insulin receptors have been found in almost all mam-
malian tissues investigated so far. Their properties have been 
examined thoroughly during the last decade. To investigate 
their structure, native or labeled insulin receptors have been 
subjected to gel filtration [1- 9], electrophoresis [10 -14], 
various centrifugation techniques [4- 8] and radiation in-
activation (15]. Recently the primary structure of the human 
insulin receptor has been determined [16]. Receptor binding 
data have been analyzed by displacement curves, Scatchard 
plotsandnon-linear curve-fitting programs. However, in spite 
of these efforts the results obtained to date do not offer a 
clear picture of the insulin receptor. While some authors have 
observed only one receptor species with a Stokes radius of 
7.2 nm and an Mr of about 350000 (1, 3, 4] others have found 
two species, the smaller of which could be generated from the 
!arger one [2, 5, 8 -10]. Furthermore, under the denaturing 
conditions ofSDS-PAGE, multiple receptor forms have been 
detected [11-14]. Resolving the problern of receptor 
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homogeneity or heterogeneity is important for the interpreta-
tion of binding data. With a few exceptions [ 6, 17, 18], insulin 
receptor binding data yield non-linear Scatchard plots. Usu-
ally this non-linearity is attributed either to the existence of 
heterogeneaus binding sites [19, 20] or to the negative cooper-
ative behavior of a single receptor class [21]. However, this 
subject is still controversial and other factors may be involved 
as weil. 
The aim of this study was to characterize the insulin re-
ceptors obtained from Triton X-100 extracts of rat liver 
microsomes. Following gel filtration of these extracts we 
found two receptor species whose structure and binding 
properties were investigated. Part of these results have pre-
vi'ously been presented in a preliminary form [22]. 
MATERIALS AND METHODS 
Bovine insulin was obtained from Hoechst (Frankfurt/ 
Main); Na 12 5 I was from Amersham-Buchler (Braunschweig); 
1251-insulin was prepared by a modification of the chlor-
amirre-T method with a specific activity of 210 jlCi/J.Lg [23]; 
Triton X-100 (spec. purified) (Triton), poly(ethyleneglycol) 
6000, dithioerythritol, N-ethylmaleimide, bovine serum 
albumin, bovine immunoglobulin G, concanavalin A, sodium 
dodecyl sulfate (SOS), acrylarnide, N,N' -methylene-
bisacrylamide and N,N,N' ,N' -tetramethylethylenediamine 
were obtained from Serva (Heidelberg); methyl-a-o-manno-
pyranoside (99% ), blue dextran, myosin, ß-galactosidase, 
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phosphorylase h, bovine serum albumin, Trizma base, and 
Trizma pre-set 8.7 were from Sigma (St Louis); Sepharose 
CL-6B, Sephadex G-50 fine, SP-Sephadex C-25, thyroglobu-
lin and ferritin (from the high-molecular-weight gel filtration 
calibration kit) were obtained from Pharmacia (Uppsala); 
aldolase, catalase, and RNA-polymerase were from Boeh-
ringer (Mannheim); spectrins I and II were prepared from 
bovine erythrocytes; all other chemieals used were of reagent 
grade. 
Preparation of rat Ii ver microsoma/ extract 
Liver microsomes were prepared from male or female 
Sprague-Dawley rats (130-150 g) by differential centrifuga-
tion as previously described [23]. The insulin receptor was 
extracted from the microsomes (20- 25 mg protein/ml) with 
1.5% (wjv) Triton X-100 at room temperature for 50 min. 
The suspensionwas diluted to a Triton concentration of0.5% 
(w/v) by addition of cold 0.01 M phosphate buffer pH 7.4. 
Insoluble material was removed by centrifugation at 
100000 x g (45 min) at 4 oc. The protein content ofthe extract 
was about 6 mgjml. The extract was stored at- 30°C without 
lass of binding activity. · 
Determination of protein was performed according to the 
metbad of Lowry et al. [24] with 0.1% bovine serum albumin 
as standard. 
125 I-Insulin-binding assay 
All binding assays were donein triplicate. 200 ).ll solubi-
lized receptor preparation (0.05- 0.15 mg protein/ml) was in-
cubated with 12 51-insulin (0.04 pmol) at 4 oc in a total volume 
of 300 ).ll phosphate buffer and in the presence of 0.06% 
Triton until a steady state was reached (40 h). The molarity 
and the pH ofthe phosphatebufferare indicated in the legends 
of the figures. In displacement studies the tubes contained 
unlabeled insulin at concentrations between 0.08 nM and 
5000 nM. After incubation the 1251-insulin-receptor complex 
was separated from unbound 1251-insulin by precipitation 
with poly(ethyleneglycol) [23] and the pellets were counted for 
radioactivity. Specific binding was determined by subtraction 
of non-specific binding in the presence of unlabeled insulin 
(5 J.tM) from total binding and is indicated as percentage 
specifically bound = 100 x cpm (specifically bound)jcpm 
(total). 
Binding data were analyzed by Scatchard plots and by a 
computerized method of non-linear curve-fitting corre-
sponding to the hinding model applied by Munson and 
Rodbard {25]. Each experimentwas fitted assuming the exis-
tence of either one dass of identical binding sites (one-site 
model), or of two classes of different binding sites (two-site 
model). 
Degradation of 1251-insulin was estimated by precipitation 
with 5% trichloroacetic acid [23]. Degradation is indicated 
as percentage degraded = 100 x cpm (trichloroacetic-acid-
soluble)jcpm (total). 
Gelfiltration ofmicrosomal extracts 
5 ml microsomal extract containing about 6 mg protein/ 
ml and 0.5% Triton were applied to a Sepharose CL-6 B 
column (2.7 x 120 cm) and eluted with the indicated buffer 
containing 0.1% Triton. Fractions of 6- 8 ml each were 
co1lected. For molecular size determinations the following 
standard proteins were used: thyroglobulin (8.5 nm), ferritin 
(6.1 nm), catalase (5.2 nm) and aldolase (4.8 nm). 
Photoajjinity labefing of the receptors 
NeB29-mono(4-azidobenzoyl)insulin (MABI) was pre-
pared according to Yip et al. [26] with the following 
modifications: 40 mg insulin was suspended in 3.2 ml 
dimethylformamide and 15 J.!l triethylamine. 0.5 ml freshly 
prepared solution of (4-azidobenzoyl)-N-hydroxysuccinimide 
in dimethylformamide (9.5 mgjml) was added. After allowing 
the reaction to proceed for 5 h at room temperature, 6 ml 
chilled 1 M acetic acidwas added and the pH adjusted to 5.4 
with 1 M NH 3 . The reaction mixturewas kcpt at 4 ,)C for 1 h 
and the precipitate recovered by centrifugation. MABI was 
separated from the precipitate by ion-exchange chromatog-
raphy on SP-Sephadex C-25 with a gradient of 0.02-0.4 M 
NaCl in 1.5 M acetic acid in the presence of 6 M urea. The 
fractions containing MABI were pooled and dialyzed first 
against 0.02 M ammonium acetate buffer pH 8.0 and then 
against H 20. After lyophilisation, MABI was desalted by gel 
filtration on a Sephadex G-50 fine column with 1 M acetic 
acid as elution buffer, lyophilized and stored at - 20 ''C in the 
dark. 
lodination of MABl was performed in the dark as de-
scribed for insulin (23]. In the radioreceptor assay 125 f-MABI 
was about 45% as potent as 1251-insulin. More than 95% of 
the radioactivity of 1251-MABI was precipitable with anti-
insulin antibodies. The solubilized insulin receptors were in-
cubated with 1251-MABI at 4°C for 20 hin the dark in 0.1 M 
phosphate buffer pH 8.0 containing 0.06% Triton. After in-
cubation, the tubes were placed on ice and ultraviolet-irradi-
ated for 10 min with a Philips HPK 125-W lamp at a distance 
· of about 15 cm. The samples were protected from the short-
wa ve ultraviolet light by a glass plate. After photolysis, 30-
50% of the specifically bound 1251-MABI was covalently 
linked. 
S DS- PAGE of the photoajjinity labeled receptors 
SDSjpolyacryhimide gel electrophoresis (PAGE) was 
carried out in slab gels according to Laemmli [27] using 
stacking gels of 3.5% acrylamide and separating ge]s with a 
linear pore gradient of 4-10% acrylamide. The total gel 
length was 230 mm. Electrophoresis was performed at 15 "C 
with a constant current of 36 mA for 5 h. Sampies were pre-
pared in sample buffer [27] containing 5% SDS and 0.5 mM 
EDTA in the absence or presence of the indicated concentra-
tions of dithioerythritol and boiled for 3 min. After 
electrophoresis, gels were stained with Coomassie blue [28], 
destained, dried and autoradiographed at - 80°C on Kodak 
X-OMAT-AR films with Dupont Hi Plus intensifying screens. 
For molecular mass determinations the following standard 
proteins were used: spectrins I (240000) and II (220000), 
myosin (205000), RNA-polymerase ß' subunit (165000) and 
ß subunit (155000), ß-galactosidase (116000), phosphoryl-
ase b (94000), and serum albumin (68000). 
RESULTS 
Preparation of peaks I and /I 
Microsomal Triton extracts were subjected to gel filtration 
on Sepharose CL-6 B. Depending on the buffer used for the 
determination of insulin binding in the eluate, two binding 
peaks (I and li) were obtained (Fig.1). Buffers of high 
molarity and basic pH yielded both peak I and peak li, 
whereas buffers of low molarity and neutral pH yielded 
peak li only. Buffers of intermediate molarity or pH produced 
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Fig.1. Preparation ofpeaks I and II. 5 ml microsomal Triton extract 
(6 mg of protcin/ml) was subjected to gel filtration on Sepharose 
CL-6 B as described in Materialsand Methods. Elution was performcd 
with 0.01 M phosphate buffer (PB) pH 7.4 containing 0.1% Triton. 
200-!ll aliquots of thc fractions were assayed for specific insulin bind-
ing with 0.1 M PB pH 8.0 (e), 0.1 M PB pH 7.4 (6), and 0.01 M PB 
pH 7.0 (0) as final assay buffers (see Materialsand Methods). Insulin 
degradation (--) and protein contcnt (--- -) were measured as 
described in Materialsand Methods. T, thyroglobulin; F, ferritin 
one mixed peak in an intermediate position. Peak I and 
peak li could not be separated completely from each other, 
but were separated from the bulk of the protein and the 
insulin-degrading activity present in microsomal Triton ex-
tracts. Both peaks could be rechromatographed symmetrically 
and without a shift of their elution volumes. Thus, during gel 
filtration no reversible or irreversible conversion of the peaks 
occurred. The same elution profiles were also obtained using 
0.01 M Tris/HCI or phosphate buffers of high mo1arity as 
elution buffers. Both binding peaks could be stored without 
lass of activity in the lyophilized or frozen state at - 30°C. 
If microsomal extracts were treated with concanavalin A 
(1 mgfmg ofextract protein, pH 7.4), 70-80% ofthe insulin 
receptors were precipitated, whereas the bulk of the extract 
protein containing all of the insulin degrading activity was 
not precipitated and thus separated [23]. The precipitate 
was solubilized by buffers containing methyl-a-n-manno-
pyranoside. When this solution was subjected to gel filtration, 
peak I and peak II were found in the same quantitative pro-
portion and with the same elution volumes shown in Fig.1. 
Therefore, both peaks are glycoproteins. 
Determination of the molecular sizes of peaks I and li by 
gel filtration on Sepharose CL-6 B yielded a Stokes radius of 
9.2 ± 0.2 nm for peak I and 8.0 ± 0.2 nm for peak II (mean 
± SO, n = 4). Thus, both peaks represent very large molec-
ular complexes. The same molecular sizes were obtained either 
if Sepharose CL-4 B was used, or if the elution buffer 
contained no Triton or bad a lower molarity. However, if 
pcaks I and li were photoaffinity labeled before gel filtration, 
smaller Stokes radii of 8.7 ± 0.2 nm (peak I*) and 7.6 ± 
0.2 nm (peak li *) were obtained. At present it is unknown 
whether peaks I* and II * lack a fragment or have undergone 
a conformationa1 change after binding of 1251-MABI and 
photolysis. 
Dependence o.f the insulin binding of peaks I and 1I 
on ionic strength and pH 
1t is obvious from Fig.1 that peaks I and II showed 
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Fig. 2. E.ffect of the concentration and the pH of phosphate buffer on 
rhe insulin hinding of.fractions from peaks 1 and 11. 200-!ll aliquots of 
fractions 50, 52, 54, 56, 58, and 60 (see Fig.1) were assayed for specitic 
insulin binding in 0.02 M (ll), 0.06 M (A), 0.11 M (0) and 0.15 M 




Fig. 3. Ejfect of the concentration and the pH ofTris/ HCI buffer on the 
insulin binding of peaks I and II. Fractions from peak I and peak II 
(corrcsponding to fractions 48-53 and 57-62 in Fig.t) were pooled 
separately. 200-~l aliquots of poolcd pcak I (above) and peak ll 
(below) were assayed for specific insulin binding in 0.03 M Tris/HCI 
(A), 0.12 M Tris/HCl (0), and 0.34 M Tris/HCI (e) at the indicated 
pH values (see Materialsand Methods) 
buffers. Therefore, fractions of peak I and peak II were ex-
amined for the dependence of insulin binding on buffer con-
centration and pH (Fig. 2). Fractions 50 and 52, which belong 
to peak I, showed minimal binding in buffers of low molarity 
and neutral pH, but maxima1 binding in high-molarity and 
basic pH buffers. In cantrast fractions 58 and 60, which belang 
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Fig.4. Scatchard plots ofpeaks I und JJ under d!f!erent bujfer conditions. Peaks T and li were pooled as described in Fig. 3. 200-~1 aliquots of 
pooled peak I (A) and peak II (B) wcre assayed für insulin binding in lhe foJlowing buffers in the presencc of increasing concentrations of 
unlabcled insulin (sec Materialsand Methods). Binding data were plotted according to Scatchard. Buffer 1, 0.06 M phosphatc buffcr (PB) 
pH 8.0/0.2 M Na2S04 (e); buffer 2, 0.1 M PB pH 8.0 (0); buffer 3, 0.06 M PB pH 7.4/0.2 M Na 2S04 (.&); huffer 4, 0.1 M PB pH 7.4 (.6.); 
buffer 5, 0.03 M PB pH 7.4 ( x ); buffer 6. 0.1 M PB pH 7.0 (.); buffcr 7, 0.01 M PB pH 7.0 (0) 
and neutral pH values. For these fractions, increasing the 
buffer molarity resulted in a decrease in insulin binding. Si-
multaneously the optimum pH shifted to the same basic pH 
values at high buffer molarity observed for peak l. Fractions 
54 and 56, which contain both peaks I and 11, exhibited inter-
mediate binding characteristics. 
Thc optimum pH was also examined in the Tris/HCl buffer 
system (Fig.3). With this buffer the same dependence of in-
sulin binding on buffer concentration and pH was observed. 
Rechromatography of peaks I and II also did not change this 
binding behavior. 
The former experiments suggested that the influence of 
buffer conccntration on insulin bindingwas an ionic strength 
effect. To verify this assumption, insulin binding was deter-
mincd in a buffer system which was composed of a phosphate 
buffer of low concentration and increasing amounts of sodium 
sulfate. As expected, the increase in salt concentration had 
the same effect on insulin binding as the increase in buffer 
concentration in Figs 2 and 3 (data not shown). 
Ana(vsis of the insulin binding of peaks I and II 
at d(fferent condi.tions of ionic strength and pH 
Fig.4 shows the Scatchard plots obtained from binding 
studies of peaks I and li investigated under seven different 
buffer conditions. Most of the plots, especially those of 
peak II, exhibit more or less pronounced non-linearity, which 
varied partially for different experiments. The steep initial 
parts of the curves of peak I for buffers 5-7 were due to a 
small contamination by peak ll. Fig. 4 shows that the dif-
ferent buffers led to a change in the slope of the curve, i. e. the 
dissociation constant, Kd. On the other band, a significant 
change of the total number of binding sites, N101 , was only 
observed for peak ll with the two low-ionic-strength buffers 
5 and 7. 
The analysis of insulin binding by the non-linear curve-
fitting program yielded data as shown in Table 1. Only the 
values of the dissociation constants for the high-affinity bind-
ing sites, Kdl> are shown, as these were highly reproducible. 
In contrast, the values of the dissociation constants for the 
low-affinity bit;tding sites, Kd 2 , are not indicated since they 
Table 1. Binding data l!f'peaks I and 1/ 
Peaks I and II were assayed for insulin binding in buffers 1 - 7 as 
described in Fig.4. The binding data were analysed using the non-
linear curve-fitting program (see Materialsand Methods). Kd 1 values 
are indicated as means ± SD (n == 6). N101 values arc taken from a 











0.50 ± 0.06 
1.04 ± 0.06 
2.25 ± 0.21 
2.90 ± 0.39 
4.09 ± 0.90 











1.11 ± 0.24 0.23 
1.02±0.19 0.21 
2.46 ± 0.30 0.25 
1.18 ± 0.17 0.26 
0.61 ± 0.05 0.18 
1.27 ± 0.15 0.23 
0.55 ± 0.10 0.14 
could not be precisely deterrnined. Usually Kd 2 was in the 
range of 5 -15 nM, but values of 2 nM or 200 nM were also 
obtained. 
Table 1 demonstrates that the Kd 1 values of both peak I 
and peak II were about 0.5 nM at their optimal buffer 
conditions. With buffers 2 and 3 both peaks had virtually the 
same binding affinity. With buffer 1, peakIbound with higher 
affinity than peak II, with buffers 4-6 the opposite was true. 
Under the conditions of low ionic strength and neutral pH 
(buffer 7) peak 11 showed its highest binding affinity, whereas 
peak I bound too poorly to be determincd. Thus, the 
dependence of the dissociation constants of peaks I and II on 
ionic strength and pH was completely different. To a lesser 
extent this was also true for the total number of binding sites, 
N101 (Table 1). For peak I, N101 was independent of the buffer 
conditions used. For peak 11, however, N101 was diminished 
for buffer 5 and especially for buffer 7. 
For all receptor preparations investigated so far, specific 
insulin binding decreases with increasing temperature. This 
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Fig. 5. SDS-P AG E o.f peaks I and I!. Peaks I and II were pooled as 
described in Fig.3. 200-111 aliquots of pooled peak T (lanes a-d) 
and peak II (lanes e-h) were photoa ffinity labeled as described in 
Materialsand Methods. Non-specific labeling was perforrned in the 
presencc of native insulin (5 11M) (lanes b, f). The labeled samples 
were then prepared for electrophoresis in the absencc (lanes a, b, e, t) 
or in the presencc of 0.5 mM (lanes c, g) or 10 mM (lanes d, h) 
dithioerythritol. After SOS-PAGE, gcls were stained, destained, dried 
and autoradiographed (see Materialsand Methods) 
examination ofthis effect revealed that for peak I the decreasc 
in insulin binding with increasing temperature was due to a 
change in its binding constants, whereas for peak II, receptor 
denaturation seemed to play an important role. 
SDS-PAGE l~j'peaks 1 and li 
When the photoaffinity-labeled peaks were subjected to 
SDS-PAGE under non-reducing conditions, peak I showed 
five receptor bands with Mr values of400000, 365000, 320000, 
290 000 and 245 000, whereas for peak II two major receptor 
bands of Mr 210000 and 115000 were found (Fig. 5). In addi-
tion, peak II occasionally revealed two minor bands of Mr 
190000 and 160000. All of these bands were labeled 
specifically. The peak II receptor bands were also produced 
aftermild reduction of peak I. After complete reduction, both 
peak I and peak II revealed one major receptor band of Mr 
130000. In addition, peak II showed a minor band of Mr 
120000, which was found tobe a deglycosylation product of 
the Mr 130000 subunit. The Mr 130000 receptor band can be 
demonstrated to be identical with the Mr 115 000 receptor 
band of the non-reduced peak li, from which it differs only 
by the extent of internal disulfi.de reduction. 
Lane c in Fig. 5 shows that peak li is generated from peak I 
by reduction. However, this reaction takes place not only 
under the denaluring conditions of SDS-PAGE, but also 
under non-denaturing conditions. When non-labeled Triton 
extracts were treated for 1 h at 4 "C with dithioerythritol (2-
285 
20 mgjml) and subjected to gel filtration, binding detetmina-
tion of the eluates revealed a marked increase of peak II and 
a corresponding dccrcase of peak I (data not shown). This 
result was confirmed by another experiment. Ifthe sulfhydryl-
blocking agent N-ethylmaleimide (5 mM) was present during 
thc preparation of liver microsomes and Triton extracts to 
prevent reduction, the amount of peak II found after gel filtra-
tion of the extracts was considerably diminished compared to 
peak I. 
DISCUSSION 
Preparation and molecular sizes of peaks I and I/ 
When insulin receptors are solubilized from rat liver 
microsomes by Triton X-100, gel filtration of the extracts 
reveales two insulin-binding peaks (I and li) with Stokes radii 
of9.2 ± 0.2 nm and 8.0 ± 0.2 nm. Since Triton extracts from 
puritied plasma membranes and nuclear envelopes of rat Ii ver 
yielded the same two peaks [29], the possibility that the two 
receptor species are derived frorn different cell compartments 
can be excluded. It must be emphasized that both peaks were 
only obtained if the binding activity in the eluate was ex-
amined with appropriate buffers. In contrast, other groups 
obtained only one receptor species and a Stokes radius of 
about 7.2 nm for the native insulin receptor on Sepharose 6 B 
or4B [1- 5, 9]. From theStokes radius of7.2 nm this receptor 
could be assumed to correspond to peak II. However, the 
receptor bands found in SDS-PAGE for this 7.2-nm receptor 
[3, 12, 13] and for the peaks I and II (Fig. 5) indicate that the 
7.2-nm receptor is identical with peak I or with a mixture of 
peak I and peak li. 
In cantrast to the authors cited above, several other groups 
have reported receptor sizes which are comparable with those 
described here [6- 8, 15]. Among these, the data of Aiyer [8] 
correspond quite well with our results. Investigating the in-
sulin receptors from turkey erythrocytes, this author found 
two receptor species after sucrose density gradient centrifuga-
tion with Stokes radii of 8.9 ± 0.3 nm (species I) and 7.6 
± 0.3 nm (species Il) as determined by Sepharose 4 B 
chromatography. Since his experiments were done using 
affinity-labeled erythrocyte membranes, the data agree very 
well with the Stokes radii of peak I* (8. 7 ± 0.2 nm) and 
peak II * (7 .6 ± 0.2 nm) we observed. 
Using SDS-PAGE, the Mr values obtained for the receptor 
species from peak I and peak II were 400000 and 210000 
respectively (Fig. 5). These values correspond weil to those of 
the (aßh and (aß) receptor forms found by others [11] and 
also correspond to the Mr values which were determined for 
the native receptor species I and II by Aiyer [81 from gel 
filtration and velocity Sedimentation experiments. 
E.f{ect (~fpH and ionic strength on the hinding behavior 
ofpeaks I and ll 
Peak 1 showed optimal binding at pH 8.0 and at high ionic 
strength, whereas peak II bound optimally at pH 7.0 and at 
low ionic strength. At the optimal conditions peak I and 
peak II bound insulin with a Kd 1 of 0.50 nM and 0.55 nM 
respectively (Table 1). 
The Scatchard plots obtained using the seven different 
buffer conditions yielded predominantly non-linear curves for 
peak I and peak II (Fig. 4). In cantrast to the Triton extracts, 
where non-linear Scatchard pJots can be interpreted by the 
presence of the two distinct receptor species, peak I and 
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peak II, the occurrence of non·linear curves for the separated 
species ofpeak I and peak II is much more difficult to explain. 
One possibility is a heterogeneity of binding sites [19, 20] 
since we observed different receptor forms after SDS-PAGE 
of peaks I and II under non·reducing conditions (Fig. 5). Fur-
thermore, heterogeneity ofthe Iigand must be considered [30]. 
This problern applies not only to the different affinities of 
1251-insulin and unlabeled insulin, but also to the heterogen-
eity of 1251-insulin itself, which was iodinated by the chlorami-
ne-T method. However, if this heterogeneaus 12 5 I-insulin was 
replaced by A 14-mono-125I-insulin, prepared according to 
J0rgensen et al. [31], non-linearity of the Scatchard plotswas 
still evident (data not shown). Similarly the degradation of 
125I-insulin during the incubation [17] should play no role 
since peak I and peak II were free of insulin-degrading activi-
ty. 
The mathematical analysis of insulin binding of peaks I 
and ll, under the different buffer conditions described, was 
performed using non-linear curve fitting. Bindingexperiments 
which yielded non-linear Scatchard plots were best fitted using 
the two-site model, whereas for linear Scatchard plots this 
model provided no improvement compared to the one-site 
model. The dissociation constants of the high-affinity binding 
sites, Kdt. and the total number of binding sites, N101 , could 
be determined with good accuracy and were used for the 
comparison of the insulin binding of peaks I and li under the 
seven buffer conditions examined (Table 1). For peak I, it is 
shown that the change of the insulin· bindingwas caused only 
by a change of the affinity of the binding sites. In contrast, 
for peak II a change both of affinity and of the nurober of 
binding sites (for buffers 5 and 7) was responsible for the 
change of insulin binding. 
At present it is not clear whether the change in affinity 
under the different conditions of pH and ionic strength is the 
result of a direct effect on the interactions between insulin and 
its receptor-binding site, or is accomplished indirectly by a 
conformational change of the receptor. In particular, it is 
unknown by which mechanism the complicated binding 
behavior of peak li is produced, which is in marked contrast 
to the rather simple dependence of peak I binding on ionic 
strength and pH. 
Generation ofpeak 1/from peak I 
Treatment of peak I with non-denaturing or denaturing 
detergents, or with different conditions of ionic strength or 
pH did not result in the generation of peak I I. In addition, in 
cantrast to the findings of others [2, 9, 1 0] we found no 
evidence that peak I was converted to peak li or another 
smaller receptor subunit in the presence ofinsulin (10- 30 ng( 
ml). 
The peak li receptor species could be produced from the 
peak I receptor only by reduction. This reaction proceeded 
not only under the denaturing conditions of SDS-PAGE 
(Fig. 5), but also und er non-denaturing conditions when non-
labeled Triton extracts were reduced with dithioerythritol. It 
could also be achieved by mild treatment of plasma 
membranes with reductants [32] (and A. Deger, unpublished 
observation). However, when the membranes were prepared 
in the presence of N-ethylmaleimide, the generation ofpeak II 
was largely inhibited. These results suggest that the reductive 
conversion of peak I to peak II may be both a physiological 
process within the intact cell membrane and an artificial pro-
cess occurring during membrane and extract preparation. In 
addition, the formation of peak II within the membrane could 
be responsible for the controversial effects on insulin binding 
observed after treatment of membranes and cells with 
dithiothreitol [15, 32- 35]. 
A comparison of peak I and peak II with the receptor 
species I and li found by Aiyer [8] shows that in both cases 
the smaller receptor species can be generated from the larger 
one (the native insulin receptor) by reduction. In addition, the 
receptor bands observed in SDS-PAGE for peaks I and II 
(Fig. 5) are largely identical with those ofthe receptor species I 
and 11 [14]. Tagether with the identity of the molecular sizes, 
these results indicate that the two receptor species found by 
our group and by Aiyer represent the same receptor species. 
The appearance of smaller subunits after gel filtration of 
the partially reduced insulin receptor has also been reported 
by others [5, 9). These subunits were able to bind insulin and 
exhibited Stokes radii of3.8 nm [9] and 3.6 nm [5] respectively. 
Maturo et al. [9] speculated that the 3.8-nm species is identical 
with the (aß) subunit of the insulin receptor, but this is in 
marked cantrast to the Stokes radius of 8.0 nm found for 
peak II. On the other hand, Baron et al. [5] postulated that 
the 3.6-nm species represents the a-subunit of the receptor, 
but these authors obtained the same sedimentation constant 
(s = 6.5) as that observed for receptor species II [8]. These 
inconsistencies remain to be clarified. 
For the discussion of the structural relationship between 
the peak I and peakii receptor species the following observa-
tions from SDS-PAGE (Fig. 5) are relevant. (a) The peak II 
receptor was generated from the peak I receptor by reduction; 
(b) All of the receptor bands produced by partial reduction 
of the peak I receptor were characteristic for the peak II re-
ceptor. After complete reduction, both peak I and peak II 
yielded the same band of Mr 130000, which represents the 
insulin-binding a-subunit of the receptor; (c) In agreement 
with others [8, 11] the M r of the solubilized peak I receptor 
was approximately twice that of the peak li receptor. From 
these results we concludc that the pcak I receptor is the di-
sulfide linked dimer of the peak li receptor. This is consistent 
with the conclusion drawn by Aiyer [8] from his studies on 
turkey erythrocytes and also corresponds to the relationship 
between the (aßh and (aß) receptor fom1s found by Czech 
et al. [11]. The physiological significance, however, of the 
conversion of the peak I receptor to the peak II receptor and 
the possible role of the peak II receptor in insulin action or 
receptor metabolism remains tobe elucidated. 
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